9 METERS BIOPHARMA, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
9 Meters Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q1 2023.
  • 9 Meters Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending March 31, 2023 was $108K, a 40% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $108K -$72K -40% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $126K -$72K -36.4% Dec 31, 2022 10-K 2023-03-28
Q3 2022 $144K -$72K -33.3% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $162K -$72K -30.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $180K -$72K -28.6% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $198K -$72K -26.7% Dec 31, 2021 10-K 2022-03-23
Q3 2021 $216K -$72K -25% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $234K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $252K Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $270K +$225K +500% Dec 31, 2020 10-K 2021-03-22
Q3 2020 $288K +$228K +380% Sep 30, 2020 10-Q 2020-11-09
Q4 2019 $45K Dec 31, 2019 10-K 2020-03-20
Q3 2019 $60K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $75K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $90K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.